OncoCyte (NAS:OCX) Days Inventory

: 0.00 (As of Sep. 2022)

View and export this data going back to 2015. Start your Free Trial

Days Inventory is also known as Days Sales of Inventory (DSI). OncoCyte's Average Total Inventories for the three months ended in Sep. 2022 was $0.00 Mil. OncoCyte's Cost of Goods Sold for the three months ended in Sep. 2022 was $2.19 Mil. Hence, OncoCyte's Days Inventory for the three months ended in Sep. 2022 was 0.00.

The historical rank and industry rank for OncoCyte's Days Inventory or its related term are showing as below:

OCX' s Days Inventory Range Over the Past 10 Years
Min: 14.72 Med: 14.72 Max: 14.72
Current: 12.68

During the past 9 years, OncoCyte's highest Days Inventory was 14.72. The lowest was 14.72. And the median was 14.72.

OCX's Days Inventory is ranked better than
95.29% of 616 companies
in the Biotechnology industry
Industry Median: 168.39 vs OCX: 12.68

OncoCyte's Days Inventory stayed the same from Sep. 2021 (0.00) to Sep. 2022 (0.00).

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. OncoCyte's Inventory-to-Revenue for the three months ended in Sep. 2022 was 0.00.

OncoCyte Days Inventory Historical Data

The historical data trend for OncoCyte's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OncoCyte Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Days Inventory

14.72

OncoCyte Quarterly Data
	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
Days Inventory																-	12.50	14.17	-	-

Competitive Comparison

For the Biotechnology subindustry, OncoCyte's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Annual Data Quarterly Data

OncoCyte Days Inventory Distribution

For the Biotechnology industry and Healthcare sector, OncoCyte's Days Inventory distribution charts can be found below:

* The bar in red indicates where OncoCyte's Days Inventory falls in comparison to its industry or sector. The grey bar indicates the Days Inventory's extreme value range as defined by GuruFocus.

OncoCyte Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

OncoCyte's Days Inventory for the fiscal year that ended in Dec. 2021 is calculated as

	Days Inventory (A: Dec. 2021 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (A: Dec. 2020 )	+	Total Inventories (A: Dec. 2021 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2021 )	*	Days in Period
=	( (0	+	0.304)	/	1 )	/	7.539	*	365
=	0.304					/	7.539	*	365
=	14.72

OncoCyte's Days Inventory for the quarter that ended in Sep. 2022 is calculated as:

	Days Inventory (Q: Sep. 2022 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (Q: Jun. 2022 )	+	Total Inventories (Q: Sep. 2022 ))	/	count )	/	Cost of Goods Sold (Q: Sep. 2022 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	2.191	*	365 / 4
=	0					/	2.191	*	365 / 4
=	0.00

OncoCyte (NAS:OCX) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

OncoCyte's Inventory Turnover for the three months ended in Sep. 2022 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	2.191	/	0
	=

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

OncoCyte's Inventory to Revenue for the three months ended in Sep. 2022 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	0	/	1.017
	=	0.00

Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.

OncoCyte Days Inventory Related Terms

Thank you for viewing the detailed overview of OncoCyte's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

OncoCyte (NAS:OCX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OncoCyte Corp (NAS:OCX) » Definitions » Days Inventory

Comparable Companies

Traded in Other Exchanges

7OC:Germany

Address

15 Cushing, Irvine, CA, USA, 92618

Website

https://www.oncocyte.com

OncoCyte Corp focuses on the discovery, development, and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. The company develops diagnostic tests based on liquid biopsies using blood or urine samples for detecting lung, bladder, and breast cancers. In addition, it also develops screening diagnostics as potential replacements for screening imaging procedures that do not meet the needs of patients, health care providers or payers. Geographically operation of the group is carried through the United States, and it earns revenue from the sale of diagnostic tests.

Executives

Josh Riggs	officer: Interim CEO	15 CUSHING, IRVINE CA 92618
Lou Silverman	director
James Yang Liu	officer: Controller, PAO	C/O ONCOCYTE CORPORATION, 15 CUSHING, IRVINE CA 92618
John Peter Gutfreund	director	C/O ONCOCYTE CORPORATION, 15 CUSHING, IRVINE CA 92618
Anish M. John	officer: SVP, Finance, and Interim CFO	C/O ONCOCYTE CORPORATION,, 15 CUSHING, IRVINE CA 92618
Pura Vida Investments, Llc	10 percent owner	512 W 22ND STREET, 7TH FLOOR, NEW YORK NY 10011
Efrem Kamen	10 percent owner	C/O PURA VIDA INVESTMENTS, LLC, 512 W 22ND STREET, 7TH FLOOR, NEW YORK NY 10011
Gisela Paulsen	officer: Chief Operating Officer	5505 ENDEAVOR LANE, MADISON WI 53719
Li Yu	officer: VP Cntrllr/Prncpl Acctng Offcr	120 NEWPORT CENTER DRIVE., NEWPORT BEACH CA 92660
Jennifer L. Carter	director	C/O DFP SPONSOR LLC, 780 THIRD AVENUE, 37TH FLOOR, NEW YORK NY 10017
Douglas T. Ross	officer: Chief Medical Officer	15 CUSHING, IRVINE CA 92618
Tony T Kalajian	officer: SVP-Chief Accounting Officer	1010 ATLANTIC AVENUE, SUITE 102, ALAMEDA CA 94501
Melinda Griffith	director	1010 ATLANTIC AVENUE, SUITE 102, ALAMEDA CA 94501
Padma Sundar	officer: SVP, Marketing & Market Access	1010 ATLANTIC AVENUE, SUITE 102, ALAMEDA CA 94501
Ronald Asbury Andrews	director	5791 VAN ALLEN WAY, CARLSBAD CA 92008